National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences

Retinitis pigmentosa-intellectual disability-deafness-hypogonadism syndrome



Other Names:
Insulin-resistant diabetes with acanthosis nigricans, hypogonadism, pigmentary retinopathy, deafness, and mental retardation (formerly); Retinitis pigmentosa-intellectual disability- labyrinthine deafness-hypogenitalism syndrome; Retinitis pigmentosa-intellectual disability-sensorineural hearing loss-hypogenitalism syndrome
Categories:

The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.
orphanet

Orpha Number: 3085

Definition
Retinitis pigmentosa - intellectual disability - deafness - hypogenitalism is an extremely rare syndromic retinitis pigmentosa characterized by pigmentary retinopathy, diabetes mellitus with hyperinsulinism, acanthosis nigricans, secondary cataracts, neurogenic deafness, short stature mild hypogonadism in males and polycystic ovaries with oligomenorrhea in females. Inheritance is thought to be autosomal recessive. It can be distinguished from Alstrom syndrome (see this term) by the presence of intellectual disability and the absence of renal insufficiency. There have been no further descriptions in the literature since 1993.

Visit the Orphanet disease page for more resources.
Last updated: 1/1/2015

This table lists symptoms that people with this disease may have. For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. This information comes from a database called the Human Phenotype Ontology (HPO) . The HPO collects information on symptoms that have been described in medical resources. The HPO is updated regularly. Use the HPO ID to access more in-depth information about a symptom.

Showing of 37 |
Medical Terms Other Names
Learn More:
HPO ID
80%-99% of people have these symptoms
Abnormality of retinal pigmentation 0007703
Acanthosis nigricans
Darkened and thickened skin
0000956
Decreased testicular size
Small testes
Small testis
[ more ]
0008734
Gynecomastia
Enlarged male breast
0000771
Hypergonadotropic hypogonadism 0000815
Hyperinsulinemia 0000842
Intellectual disability
Mental deficiency
Mental retardation
Mental retardation, nonspecific
Mental-retardation
[ more ]
0001249
Nystagmus
Involuntary, rapid, rhythmic eye movements
0000639
Sensorineural hearing impairment 0000407
Short stature
Decreased body height
Small stature
[ more ]
0004322
Type II diabetes mellitus
Noninsulin-dependent diabetes
Type 2 diabetes
Type II diabetes
[ more ]
0005978
30%-79% of people have these symptoms
Brachydactyly
Short fingers or toes
0001156
Broad foot
Broad feet
Wide foot
[ more ]
0001769
Cataract
Clouding of the lens of the eye
Cloudy lens
[ more ]
0000518
Coarse facial features
Coarse facial appearance
0000280
Cryptorchidism
Undescended testes
Undescended testis
[ more ]
0000028
Delayed skeletal maturation
Delayed bone maturation
Delayed skeletal development
[ more ]
0002750
Dry skin 0000958
Keloids 0010562
Obesity
Having too much body fat
0001513
Secondary amenorrhea
Previous menstrual periods stop
0000869
Short toe
Short toes
Stubby toes
[ more ]
0001831
Visual impairment
Impaired vision
Loss of eyesight
Poor vision
[ more ]
0000505
5%-29% of people have these symptoms
Cerebellar atrophy
Degeneration of cerebellum
0001272
Hyperlordosis
Prominent swayback
0003307
Kyphosis
Hunched back
Round back
[ more ]
0002808
Polycystic ovaries 0000147
Percent of people who have these symptoms is not available through HPO
Abnormality of the ear 0000598
Autosomal recessive inheritance 0000007
Broad palm
Broad hand
Broad hands
Wide palm
[ more ]
0001169
Cerebral atrophy
Degeneration of cerebrum
0002059
Elevated hepatic transaminase
High liver enzymes
0002910
Insulin-resistant diabetes mellitus
Insulin resistant diabetes
Insulin-resistant diabetes
[ more ]
0000831
Pigmentary retinopathy 0000580
Rod-cone dystrophy 0000510
Sparse hair 0008070
Subcapsular cataract 0000523
Showing of 37 |
Last updated: 7/1/2020

If you need medical advice, you can look for doctors or other healthcare professionals who have experience with this disease. You may find these specialists through advocacy organizations, clinical trials, or articles published in medical journals. You may also want to contact a university or tertiary medical center in your area, because these centers tend to see more complex cases and have the latest technology and treatments.

If you can’t find a specialist in your local area, try contacting national or international specialists. They may be able to refer you to someone they know through conferences or research efforts. Some specialists may be willing to consult with you or your local doctors over the phone or by email if you can't travel to them for care.

You can find more tips in our guide, How to Find a Disease Specialist. We also encourage you to explore the rest of this page to find resources that can help you find specialists.

Healthcare Resources


Research helps us better understand diseases and can lead to advances in diagnosis and treatment. This section provides resources to help you learn about medical research and ways to get involved.

Patient Registry

  • A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Retinitis pigmentosa-intellectual disability-deafness-hypogonadism syndrome. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. Learn more about registries.

    Registries for Retinitis pigmentosa-intellectual disability-deafness-hypogonadism syndrome:
    My Retina Tracker®
     

Support and advocacy groups can help you connect with other patients and families, and they can provide valuable services. Many develop patient-centered information and are the driving force behind research for better treatments and possible cures. They can direct you to research, resources, and services. Many organizations also have experts who serve as medical advisors or provide lists of doctors/clinics. Visit the group’s website or contact them to learn about the services they offer. Inclusion on this list is not an endorsement by GARD.

Organizations Supporting this Disease


These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.

In-Depth Information

  • The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
  • Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine. 
  • Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
  • PubMed is a searchable database of medical literature and lists journal articles that discuss Retinitis pigmentosa-intellectual disability-deafness-hypogonadism syndrome. Click on the link to view a sample search on this topic.

Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know.